There has been recent progress in understanding the molecular basis of two key aspects of the immunobiology of Treponema pallidum, the antigenic inertness of its surface, and its resistance to killing by immune mechanisms. Freeze-fracture electron microscopy has shown that the outer membrane of T. pallidum contains approximately two orders of magnitude less transmembrane protein than that of gram negative bacteria. We have learned that this rare outer membrane protein, which has been given the acronym, TROMP, can be aggregated by antibodies from rabbits immune to syphilitic infection. Such antibody mediated TROMP aggregation appears to be a prerequisite for efficient complement activation and killing of T. pallidum. The primary focus of this proposal is the identification and characterization of TROMP. The fragility of T. pallidum, the absence of a genetic exchange system for spirochetes, and the rarity of TROMP are considerations in determining its identity definitively. We have developed a surrogate genetic system using a cloning vector which facilitates construction of fusions between the signal sequences of T. pallidum genes and an alkaline phosphatase gene from which the signal sequence has been removed. This phoA vector, pMG1, has been used to express T. pallidum-phoA fusion proteins which correspond to the genes which might be identifiable by TnphoA insertion were it possible to use this transposon in T.pallidum. It is possible to identify those T. pallidum-alkaline phosphatase fusion proteins which remain anchored to the cytoplasmic membrane because they have noncleavable signal sequences. The fusion proteins with cleavable signal sequences can be grouped into those which are acylated by E. coli and correspond to T. pallidum lipoproteins, those which correspond to T. pallidum periplasmic proteins. and those with membrane spanning sequences, which will be regarded as TROMP candidates. Rabbits will be immunized with cloned TROMP candidates. The resulting antisera will be used in an assay for demonstrating antibody to TROMP by freeze-fracture electron microscopy, for in vitro treponemicidal assays, and for in vitro assays which measure the ability of T. pallidum to adhere to cells, to fibronectin, and to invade the intercellular junctions of endothelial monolayers. The results of these in vitro studies will be correlated with the outcomes of intradermal challenge experiments with the immunized rabbits. To test the idea that antibodies with specificity for subsurface targets, such as the cytoplasmic membrane, may enhance the efficiency of killing, we will identify two relatively abundant proteins of the cytoplasmic membrane which have multiple membrane spanning sequences and study these proteins in conjunction with the TROMP candidates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI021352-09
Application #
3131376
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1984-09-30
Project End
1996-07-31
Budget Start
1992-09-01
Budget End
1993-07-31
Support Year
9
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Blanco, David R; Champion, Cheryl I; Dooley, Alek et al. (2005) A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum. Infect Immun 73:3083-95
Blanco, David R; Champion, Cheryl I; Lovett, Michael A (2005) Use of the skin protection assay in experimental syphilis to assess protective immunity against a specific Treponema pallidum surface epitope. FEMS Microbiol Lett 249:171-5
Champion, Cheryl I; Blanco, David R; Lovett, Michael A (2005) Quantitative assessment of protection in experimental syphilis. Infect Immun 73:5923-7
Blanco, D R; Whitelegge, J P; Miller, J N et al. (1999) Demonstration by mass spectrometry that purified native Treponema pallidum rare outer membrane protein 1 (Tromp1) has a cleaved signal peptide. J Bacteriol 181:5094-8
Zhang, H H; Blanco, D R; Exner, M M et al. (1999) Renaturation of recombinant Treponema pallidum rare outer membrane protein 1 into a trimeric, hydrophobic, and porin-active conformation. J Bacteriol 181:7168-75
Lewinski, M A; Miller, J N; Lovett, M A et al. (1999) Correlation of immunity in experimental syphilis with serum-mediated aggregation of Treponema pallidum rare outer membrane proteins. Infect Immun 67:3631-6
Blanco, D R; Champion, C I; Lewinski, M A et al. (1999) Immunization with Treponema pallidum outer membrane vesicles induces high-titer complement-dependent treponemicidal activity and aggregation of T. pallidum rare outer membrane proteins (TROMPs). J Immunol 163:2741-6
Skare, J T; Foley, D M; Hernandez, S R et al. (1999) Cloning and molecular characterization of plasmid-encoded antigens of Borrelia burgdorferi. Infect Immun 67:4407-17
Shang, E S; Skare, J T; Exner, M M et al. (1998) Isolation and characterization of the outer membrane of Borrelia hermsii. Infect Immun 66:1082-91
Champion, C I; Blanco, D R; Exner, M M et al. (1997) Sequence analysis and recombinant expression of a 28-kilodalton Treponema pallidum subsp. pallidum rare outer membrane protein (Tromp2). J Bacteriol 179:1230-8

Showing the most recent 10 out of 43 publications